The effects of anticancer agents, amino acids and chelating agents on the distribution and excretion of
59FeCl
3, on the catalase activity of liver and blood in Ehrlich ascites cancer bearing-mice were examined with the following results.
1. In ascites cancer cells intraperitoneally implanted mice, the time course of the changes of
59Fe distribution were examined. At 24 hours after the
59Fe administration, its concentration in the kidney was decreased in many cases with no changes in the other organs. Liver catalase activity was decreased about half in cancer bearing-mice compared with the normal.
2. In subcutaneously implanted mice, the time course of the changes of
59Fe distribution were examined. Blood
59Fe concentration was decreased at 120 hours after the administration without any changes in the other organs.
3. The effects of continual administration of anticancer agents to cancer-bearing mice were examined. In Mitomycin C treated group,
59Fe concentration was decreased in blood and its concentration was increased in liver along with an inhibiting effect on ascites retention. Depressed liver catalase activity was returned to normal levels in this group. In Toyomycin treated group,
59Fe distribution did not change in all organs, but liver catalase activity was returned to the normal and ascites retention was inhibited in this group. After the administration of Merphyrin,
59Fe distribution in liver and spleen was decreased in normal mice, but same changes were not seen in cancer bearing-mice. Nitromin did not affect both
59Fe distribution in organs and ascites retention. In cortisol acetate treated group, the ascites retention was inhibited in larger dose, but
59Fe distribution was not changed.
4. Anticancer agents, amino acids and chelating agents were administered intraperitoneally with
59Fe to cancer bearing-mice and its effect on
59Fe distribution was examined.
59Fe distribution was not changed in many organs with one or two exception.
5. At 1 hour after the intraperitoneal injection of
59Fe, ascites was removed and the distribution of
59Fe in cancer cells was examined. Its concentration was 5. 2% of injected dose per ml, but this grade was decreased to 0. 78% after the washing of cancer cells. Using above washed cancer cells the incorporation of
59Fe into subcellular fraction was examined. Nuclear fraction had the highest concentration, followed by supernatant, microsomal and mitochondrial fractions in the descending order.
View full abstract